Yasin Keshvargar
Lawyers
Filters
ADC Therapeutics $60 million private placement
We advised ADC Therapeutics on the transaction involving its common shares and pre-funded warrants
Vistra $2 billion secured notes offering
The investment-grade notes are due 2028, 2030 and 2035
Spirit Airlines chapter 11 filing
We are advising Spirit Airlines in connection with its chapter 11 bankruptcy cases
Energizer Holdings $400 million notes offering
The high-yield notes are due 2033
Oscar Health $410 million convertible senior subordinated notes and capped call transactions
The 2.25% convertible notes are due 2030
Bruker mandatory convertible preferred stock offering
The preferred stock will be listed on Nasdaq
Precigen $125 million financing
We advised Precigen on the loan agreement
Eli Lilly $6.75 billion notes offering
The investment-grade offering consisted of seven tranches
Tempus AI $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
PureCycle Technologies $300 million private placement
We advised the placement agents on the equity offering